Discovering New Liver Disease Treatments The New York Academy of Sciences

Non-alcoholic fatty liver disease is set to become the most common cause of liver transplant in the coming decade. Although almost one-third of adults worldwide suffer from the condition, which is also associated with diabetes and obesity, there are currently no approved treatments. This podcast will discuss the basis of liver disease as well as several cutting edge approaches that are being developed to model the disease and speed the discovery of new therapeutics.

This podcast has been made possible with support from Emulate (https://www.emulatebio.com).